|
1
|
van Wegberg AMJ, MacDonald A, Ahring K,
Bélanger-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J,
Feillet F, Giżewska M, et al: The complete European guidelines on
phenylketonuria: Diagnosis and treatment. Orphanet J Rare Dis.
12(162)2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Vieira Neto E, Laranjeira F, Quelhas D,
Ribeiro I, Seabra A, Mineiro N, D M Carvalho L, Lacerda L and G
Ribeiro M: Mutation analysis of the PAH gene in phenylketonuria
patients from Rio de Janeiro, Southeast Brazil. Mol Genet Genomic
Med. 6:575–591. 2018.PubMed/NCBI View
Article : Google Scholar : (Epub ahead of
print).
|
|
3
|
van Spronsen FJ, Blau N, Harding C,
Burlina A, Longo N and Bosch AM: Phenylketonuria. Nat Rev Dis
Primers. 7(36)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dababneh S, Alsbou M, Taani N, Sharkas G,
Ismael R, Maraqa L, Nemri O, Al-Jawaldeh H, Kopti N, Atieh E and
Almasri A: Epidemiology of phenylketonuria disease in Jordan:
Medical and nutritional challenges. Children (Basel).
9(402)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Blau N, van Spronsen FJ and Levy HL:
Phenylketonuria. Lancet. 376:1417–1427. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Schuck PF, Malgarin F, Cararo JH, Cardoso
F, Streck EL and Ferreira GC: Phenylketonuria pathophysiology: On
the role of metabolic alterations. Aging Dis. 6:390–399.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
van Spronsen FJ, van Wegberg AM, Ahring K,
Bélanger-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J,
Feillet F, Giżewska M, et al: Key European guidelines for the
diagnosis and management of patients with phenylketonuria. Lancet
Diabetes Endocrinol. 5:743–756. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Elhawary NA, AlJahdali IA, Abumansour IS,
Elhawary EN, Gaboon N, Dandini M, Madkhali A, Alosaimi W, Alzahrani
A, Aljohani F, et al: Genetic etiology and clinical challenges of
phenylketonuria. Hum Genomics. 16(22)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Woo SLC, Lidsky AS, Güttler F, Chandra T
and Robson KJH: Cloned human phenylalanine hydroxylase gene allows
prenatal diagnosis and carrier detection of classical
phenylketonuria. Nature. 306:151–155. 1983.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Hillert A, Anikster Y, Belanger-Quintana
A, Burlina A, Burton BK, Carducci C, Chiesa AE, Christodoulou J,
Đorđević M, Desviat LR, et al: The genetic landscape and
epidemiology of phenylketonuria. Am J Hum Genet. 107:234–250.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Scriver CR, Hurtubise M, Konecki D,
Phommarinh M, Prevost L, Erlandsen H, Stevens R, Waters PJ, Ryan S,
McDonald D and Sarkissian C: PAHdb 2003: What a locus-specific
knowledgebase can do. Hum Mutat. 21:333–344. 2003.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sambrook J and Russell DW: Molecular
Cloning: A Laboratory Manual. Vol 1. 3rd edition. Cold Spring
Harbor Laboratory Press, New York, ΝΥ, 2001.
|
|
13
|
Zastrow DB, Baudet H, Shen W, Thomas A, Si
Y, Weaver MA, Lager AM, Liu J, Mangels R, Dwight SS, et al: Unique
aspects of sequence variant interpretation for inborn errors of
metabolism (IEM): The ClinGen IEM working group and the
phenylalanine hydroxylase gene. Hum Mutat. 39:1569–1580.
2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Nykamp K, Anderson M, Powers M, Garcia J,
Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M, et
al: Sherloc: A comprehensive refinement of the ACMG-AMP variant
classification criteria. Genet Med. 19:1105–1117. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ajami N, Soleimani A, Jafarzadeh-Esfehani
R, Hasanpour M, Rashid Shomali R and Abbaszadegan MR: Mutational
landscape of phenylketonuria in Iran. J Cell Mol Med. 27:2457–2466.
2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Jeannesson-Thivisol E, Feillet F, Chéry C,
Perrin P, Battaglia-Hsu SF, Herbeth B, Cano A, Barth M, Fouilhoux
A, Mention K, et al: Genotype-phenotype associations in French
patients with phenylketonuria and importance of genotype for full
assessment of tetrahydrobiopterin responsiveness. Orphanet J Rare
Dis. 10(158)2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kleiman S, Bernstein J, Schwartz G,
Eisensmith RC, Woo SL and Shiloh Y: A defective splice site at the
phenylalanine hydroxylase gene in phenylketonuria and benign
hyperphenylalaninemia among Palestinian Arabs. Hum Mutat.
1:340–343. 1992.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Carducci C, Amayreh W, Ababneh H, Mahasneh
A, Al Rababah B, Al Qaqa K, Al Aqeel M, Artiola C, Tolve M, D'Amici
S, et al: Molecular genetics of phenylketonuria and
tetrahydrobiopterin deficiency in Jordan. JIMD Rep. 55:59–67.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Aldámiz-Echevarría L, Llarena M, Bueno MA,
Dalmau J, Vitoria I, Fernández-Marmiesse A, Andrade F, Blasco J,
Alcalde C, Gil D, et al: Molecular epidemiology, genotype-phenotype
correlation and BH4 responsiveness in Spanish patients with
phenylketonuria. J Hum Genet. 61:731–744. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang R, Shen N, Ye J, Han L, Qiu W, Zhang
H, Liang L, Sun Y, Fan Y, Wang L, et al: Mutation spectrum of
hyperphenylalaninemia candidate genes and the genotype-phenotype
correlation in the Chinese population. Clin Chim Acta. 481:132–138.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhu T, Ye J, Han L, Qiu W, Zhang H, Liang
L and Gu X: Variations in genotype-phenotype correlations in
phenylalanine hydroxylase deficiency in Chinese Han population.
Gene. 529:80–87. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yan Y, Zhang C, Jin X, Zhang Q, Zheng L,
Feng X, Hao S, Gao H and Ma X: Mutation spectrum of PAH gene in
phenylketonuria patients in Northwest China: Identification of
twenty novel variants. Metab Brain Dis. 34:733–745. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Esfahani MS and Vallian S: A comprehensive
study of phenylalanine hydroxylase gene mutations in the Iranian
phenylketonuria patients. Eur J Med Genet.
62(103559)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Al-Faris MZ and Takruri HR: Study on the
prevalence of phenylketonuria in Jordan and assessment of follow-up
efforts and dietary management of patients with this disease. Med J
Nutrition Metab. 7:95–106. 2014.
|
|
25
|
Al-Qa K, Amayreh W and Al-Hawamdeh A:
Spectrum of inborn errors of metabolism in Jordan: Five years
experience at King Hussein medical center. J R Med Serv. 19:37–41.
2012.
|
|
26
|
Gundorova P, Stepanova AA, Kuznetsova IA,
Kutsev SI and Polyakov AV: Genotypes of 2579 patients with
phenylketonuria reveal a high rate of BH4 non-responders in Russia.
PLoS One. 14(e0211048)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Guldberg P, Henriksen KF, Sipilä I,
Güttler F and De La Chapelle A: Phenylketonuria in a low incidence
population: Molecular characterisation of mutations in Finland. J
Med Genet. 32:976–978. 1995.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Muntau AC, Adams DJ, Bélanger-Quintana A,
Bushueva TV, Cerone R, Chien YH, Chiesa A, Coşkun T, de Las Heras
J, Feillet F, et al: International best practice for the evaluation
of responsiveness to sapropterin dihydrochloride in patients with
phenylketonuria. Mol Genet Metab. 127:1–11. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Muntau AC, Du Moulin M and Feillet F:
Diagnostic and therapeutic recommendations for the treatment of
hyperphenylalaninemia in patients 0-4 years of age. Orphanet J Rare
Dis. 13(173)2018.PubMed/NCBI View Article : Google Scholar
|
![Electropherogram of the novel variant
[c.781del; p.(Arg261Glufs80)]. The parents are heterozygous and the
affected children are homozygous.](/article_images/br/23/3/br-23-03-02029-g01.jpg)
